German Pharma Stock News

Sartorius Aktiengesellschaft recently reported past results for the second quarter and first half of 2026, with second-quarter sales of €911.8 million and net income of €65.9 million, alongside six-month sales of €1.81 billion and net income of €122.2 million, all higher than the prior year’s levels. The sharper increase in net income than in sales suggests improved operational efficiency and cost management within Sartorius’s business over the period. We’ll now examine how this improved...

Deutsche Lufthansa (XTRA:LHA) is back in focus after recent share price swings, with the stock up 1.7% over the past day but down about 9.6% over the past month. See our latest analysis for Deutsche Lufthansa. For context, Deutsche Lufthansa’s share price return has gained 7% over the past week but is still down about 9.6% over the past month, while the 1 year total shareholder return stands at 24.8%, suggesting momentum has been rebuilding over the medium term. If these moves have you...

Bayerische Motoren Werke (XTRA:BMW) is back in focus after announcing a voluntary redundancy programme in Germany, alongside quarterly results that showed lower sales and net income compared with the same periods in 2025. See our latest analysis for Bayerische Motoren Werke. At a share price of €60.18, Bayerische Motoren Werke has seen short term momentum pick up, with a 7 day share price return of 5.73% and 30 day return of 5.10%. However, the year to date share price return is still down...

In late July 2026, TeamViewer SE reported half-year 2026 results showing sales of €365.92 million and net income of €64.29 million, with basic and diluted earnings per share from continuing operations of €0.41 versus €0.33 a year earlier. The company also highlighted an adjusted EBITDA margin of 43.2%, growing enterprise demand for its TeamViewer One platform, and a new partnership with ServiceNow alongside FedRAMP in progress status to access the US federal market. Next, we’ll examine how...

Allianz (XTRA:ALV) is back in focus after agreeing to buy HSBC’s Singapore life and health insurance unit for $2.09b, along with a 15-year exclusive bancassurance partnership across the city-state. See our latest analysis for Allianz. The HSBC Singapore deal comes at a time when Allianz’s momentum is already positive, with a 30-day share price return of 4.11% and a 90-day share price return of 10.82%, alongside a 5-year total shareholder return of 185.20%. If this kind of corporate activity...

Porsche stock came into this earnings day having edged down about 3% over the past week, yet it still carries a rich trailing P/E of 47.4x that prices in a lot of faith. The headline from this quarter is simple: profit quality is under pressure while the valuation remains demanding. Q2 2026 net income of €737m sits inside a 12 month story where net margin is just 2.4% compared with 5.6% a year earlier and the dividend is not well covered by earnings or free cash flow. The market reaction now...

BASF stock came into this earnings day with a solid rebound behind it, up about 9.5% over the past month. However, the real story is what sits under the hood. The market is reacting to a chemicals giant that just reported a very sharp swing in profitability, helped by a €3.5b after tax gain from the Coatings sale. The emotional tug of war is clear. Bulls are focusing on a 54% jump in Q2 EBITDA before special items to €2.4b and a higher full year EBITDA target. Skeptics are watching negative...

Redcare Pharmacy stock came into this earnings print on the back of a strong 90 day run, yet the latest move now hinges on a single question: Is the market reacting to genuine profit traction or just momentum fatigue? The headline is simple. The online pharmacy group pushed quarterly revenue to €853.5m and swung from a loss in Q1 to a modest €4.7m profit with positive earnings per share. The real story for investors is whether this early return to profitability justifies the recent rally or...

Mühlbauer Holding went into this earnings season with a value label and a share price that has barely moved over the past month, yet the latest numbers tell a more forceful story. The stock closed at €39.6 on 30 July while the trailing twelve month net profit margin now sits at 6.6%, up from 2.6% a year earlier, and earnings have risen sharply over that period. The headline today is clear: profitability in this machinery specialist has recovered far faster than the share price suggests. If...

Logwin’s share price closed flat at €284 after the half year 2026 release, which indicates the market has not made up its mind. Yet the core earnings story points to pressure. Net profit margins over the last year sit at 4%, slightly below the prior 4.2%, while earnings per share on a trailing twelve month basis are lower than in recent periods. Investors are treating the stock as fairly valued for now, even though the earnings trend looks softer and forecasts point to further declines. The...

Nordex stock went into this earnings day under pressure, down about 14% over the past month and about 18% over the past quarter, with investors clearly braced for disappointment. Instead, the company delivered a clean headline that goes straight to profitability. Second quarter 2026 revenue reached €2.18b with net profit of €111.5m and an EBITDA margin a touch above 10%, which is high for onshore wind equipment. The real story is margin repair, not just revenue size, and that is what will...

Befesa (XTRA:BFSA) is back in focus after reporting second quarter and half year 2026 results, with adjusted EBITDA at €124 million and management reaffirming full year guidance while detailing its Bernburg expansion plans. See our latest analysis for Befesa. Befesa’s recent earnings update and Bernburg expansion have come as the share price has risen 16.08% over the past month and delivered a 35.20% 1 year total shareholder return, although the 5 year total shareholder return is still down...

Wacker Chemie (XTRA:WCH) drew fresh attention after reporting half year 2026 earnings, with sales of €2,923.2 million and net income of €351.2 million, compared with a net loss in the prior year period. See our latest analysis for Wacker Chemie. The latest half year earnings news comes against a mixed backdrop for Wacker Chemie. The stock’s 1 day share price return of 1.84% and year to date share price return of 20.36% sit alongside a 1 year total shareholder return of 29.71%, although the 3...

Nemetschek stock reacts to Q2 2026 earnings jump Nemetschek (XTRA:NEM) is back in focus after reporting second quarter 2026 earnings with higher sales, revenue and net income, alongside increased earnings per share from continuing operations. See our latest analysis for Nemetschek. The strong Q2 report has arrived after a sharp short term rebound in Nemetschek's share price, with a 24% 7 day share price return and 22% 30 day share price return. However, the year to date share price return has...

Why Deutsche Bank’s latest earnings and buyback matter for shareholders Deutsche Bank (XTRA:DBK) just reported Q2 2026 results and a record first half, alongside completing one share repurchase program and authorizing a new €500 million buyback funded from 2026 net income. For Q2 2026, Deutsche Bank reported net interest income of €4,549 million compared with €3,837 million a year earlier. Net income for the quarter was €1,850 million versus €1,687 million in the prior year period. Basic...

Krones (XTRA:KRN) is back in focus after its second quarter 2026 earnings, which showed relatively stable sales and net income, along with a reaffirmed full year outlook and a sizeable order backlog. See our latest analysis for Krones. The recent earnings update appears to have shifted sentiment, with Krones showing a 1-day share price return of 3.34% and a 7-day share price return of 5.00%, even though the year to date share price return is down 13.53% and the 1-year total shareholder return...

As the European market navigates heightened geopolitical tensions and fluctuating oil prices, indices like the STOXX Europe 600 have shown resilience with modest gains, buoyed by robust corporate earnings reports. In this climate, dividend stocks can offer a steady income stream and potential stability, making them an attractive consideration for investors seeking to balance growth with income in their portfolios.

Trade walls are rising again, and that matters directly for your portfolio. Tougher US and EU policies, new carbon border costs and persistent competition from China are all reshaping how global trade works and where profits are earned. Export oriented growth now faces more roadblocks, which can pressure companies that rely heavily on cross border supply chains and emerging market demand. This article looks at 3 stocks that appear especially exposed to the latest protectionist push. Each one...

Legacy European carmakers such as BMW are under pressure as Chinese electric vehicle competitors push hard on price and speed of product launches. Fresh plans to cut up to 8,000 jobs in Germany show how serious the cost reset has become, especially for companies still investing heavily in combustion models while funding the shift to EVs. For investors, this news is a reminder to look closely at which stocks may feel the squeeze and which could gain ground. This article breaks down 3 stocks...

TeamViewer stock closed at €6.42 after a strong run into the print, with the trailing P/E sitting at 7.8x against much richer software peers. The headline from this earnings release is the profit story. Net income from continuing operations over the trailing twelve months stands at €130.3m with a 17.4% net margin and earnings quality flagged as high. The market now has to decide whether this level of profitability justifies re-rating a heavily discounted software stock or whether lingering...

Europe’s new packaging rules are turning recyclability from a nice to have into a hard requirement, and that is starting to reshape where capital flows. The EU’s PPWR framework raises the bar on how much packaging must be recyclable, which puts pressure on companies that are slow to adapt and creates room for specialists in recycling friendly materials and machinery. For investors, this is less about guessing the next trend and more about understanding who already has the right technology and...

Bayer (XTRA:BAYN) has drawn fresh attention after partnering with Henry Ford Health to widen clinical trial access, using data and AI to refine trial design across cardiovascular, oncology, and women’s health programs. See our latest analysis for Bayer. Against this backdrop, Bayer’s share price has moved to €47.23, with a 90 day share price return of 28.97% and a 1 year total shareholder return of 63.58%. This points to strengthening momentum as investors weigh recent partnerships and bond...

Deutsche Börse AG recently reported its half-year 2026 results, posting sales of €3,628 million and net income of €1,154 million, alongside higher basic and diluted earnings per share from continuing operations compared with a year earlier. The company also raised its full-year 2026 outlook, now targeting €5.70 billion in net revenue and expecting total net revenue to exceed €6.40 billion, underlining management’s confidence in the current business mix. With this upgraded 2026 net revenue...

Artificial intelligence stocks are sitting at the center of many of today’s biggest market conversations, from chips and cloud to software and large language models like ChatGPT. With inflation trends, energy prices, central bank decisions, and major tech earnings all shaping sentiment week to week, a focused AI Stocks screener can help you cut through the noise and zero in on companies directly tied to this shift. This article highlights 3 of the most interesting stocks from that screener,...